LRRK2 and Parkinson disease: Upregulation of miR-184* and let-7 could attenuate the neurotoxic effects of mutant LRRK2, which suggested that LRRK2 may associate with PD pathogenesis via miRNA pathway modulation, therefore, highlighting new possible therapeutic strategies for PD (Gehrke et al., 2010).